Filing Details
- Accession Number:
- 0000905148-16-002139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-20 16:28:06
- Reporting Period:
- 2016-12-16
- Filing Date:
- 2016-12-20
- Accepted Time:
- 2016-12-20 16:28:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1372218 | Cpmg Inc | 2000 Mckinney Ave., Ste 2125 Dallas TX 75201 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2016-12-16 | 20,033 | $22.99 | 280,500 | No | 4 | P | Indirect | By Willet Fund, LP |
| Class A Common Stock | Acquisiton | 2016-12-16 | 1,330 | $22.99 | 37,689 | No | 4 | P | Indirect | By Crested Crane, LP |
| Class A Common Stock | Acquisiton | 2016-12-16 | 7,990 | $22.99 | 63,001 | No | 4 | P | Indirect | By Flamingo Fund, LP |
| Class A Common Stock | Acquisiton | 2016-12-16 | 29,040 | $22.99 | 229,122 | No | 4 | P | Indirect | By Gallopavo, LP |
| Class A Common Stock | Acquisiton | 2016-12-16 | 64,250 | $22.99 | 307,937 | No | 4 | P | Indirect | By Roadrunner Fund, LP |
| Class A Common Stock | Acquisiton | 2016-12-16 | 42,110 | $22.99 | 332,230 | No | 4 | P | Indirect | By Sandpiper Fund, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Willet Fund, LP |
| No | 4 | P | Indirect | By Crested Crane, LP |
| No | 4 | P | Indirect | By Flamingo Fund, LP |
| No | 4 | P | Indirect | By Gallopavo, LP |
| No | 4 | P | Indirect | By Roadrunner Fund, LP |
| No | 4 | P | Indirect | By Sandpiper Fund, LP |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 108,285 | Indirect | By Mallard Fund, LP |
| Class A Common Stock | 53,269 | Indirect | By Blackwell Partners, LLC |
| Class A Common Stock | 333,021 | Indirect | By Yellow Warbler, LP |
| Class A Common Stock | 160,265 | Indirect | By Kestrel Fund, LP |
| Class A Common Stock | 11,076 | Indirect | By CD Fund, LP |
| Class A Common Stock | 134 | Indirect | By Redbird Life Sciences Partners, LP |
| Class A Common Stock | 113 | Direct |
Footnotes
- This price reflects the weighted average purchase price for open-market purchases on December 16, 2016, within a $1.00 range. The actual prices for these transactions range from $22.885 to $23.00, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The Reporting Person is the investment manager of each of: Blackwell Partners, LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Billionaire Hedge Funds
